283 related articles for article (PubMed ID: 34148071)
21. Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer's Disease.
Polis B; Gurevich V; Assa M; Samson AO
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540372
[TBL] [Abstract][Full Text] [Related]
22. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
[TBL] [Abstract][Full Text] [Related]
23. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
[TBL] [Abstract][Full Text] [Related]
24. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
25. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.
Barton SM; Janve VA; McClure R; Anderson A; Matsubara JA; Gore JC; Pham W
J Alzheimers Dis; 2019; 67(2):503-513. PubMed ID: 30584141
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis E; Hascup KN; Hascup ER
J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
[TBL] [Abstract][Full Text] [Related]
29. Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice.
Choi HJ; Park JH; Jeong YJ; Hwang JW; Lee S; Lee H; Seol E; Kim IW; Cha BY; Seo J; Moon M; Hoe HS
Mol Brain; 2022 Jul; 15(1):63. PubMed ID: 35850693
[TBL] [Abstract][Full Text] [Related]
30. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy.
Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S
Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212
[TBL] [Abstract][Full Text] [Related]
31. Multi-faceted therapeutic strategy for treatment of Alzheimer's disease by concurrent administration of etodolac and α-tocopherol.
Elfakhri KH; Abdallah IM; Brannen AD; Kaddoumi A
Neurobiol Dis; 2019 May; 125():123-134. PubMed ID: 30710675
[TBL] [Abstract][Full Text] [Related]
32. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
[TBL] [Abstract][Full Text] [Related]
33. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
35. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.
Caccamo A; Oddo S; Tran LX; LaFerla FM
Am J Pathol; 2007 May; 170(5):1669-75. PubMed ID: 17456772
[TBL] [Abstract][Full Text] [Related]
36. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
[TBL] [Abstract][Full Text] [Related]
37. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
38. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
39. Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe/PS1 Mice.
ElAli A; Bordeleau M; Thériault P; Filali M; Lampron A; Rivest S
Neuropsychopharmacology; 2016 Apr; 41(5):1297-307. PubMed ID: 26349911
[TBL] [Abstract][Full Text] [Related]
40. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.
Bolmont T; Clavaguera F; Meyer-Luehmann M; Herzig MC; Radde R; Staufenbiel M; Lewis J; Hutton M; Tolnay M; Jucker M
Am J Pathol; 2007 Dec; 171(6):2012-20. PubMed ID: 18055549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
